The results of the present experiments represent a step toward understanding the functional genomics of ERICH3. The results also point toward future studies of the functional basis for its role in SSRI response—a role that may involve neurotransmitter vesicular function, future studies of which might contribute to our understanding of individual variation in both MDD disease risk and antidepressant treatment response. Here, ERICH3 is linked to major depressive disorder.